The CJC-1295 w/o DAC 5mg + IPA 5mg blend is a synergistic growth-hormone–releasing combination that boosts natural GH production for improved recovery, fat loss, and anti-aging benefits. This duo enhances collagen synthesis, supports lean muscle growth, and promotes deeper sleep and increased energy. Supplementation helps optimize metabolism, accelerate healing, and improve overall vitality by gently stimulating the body’s natural hormone pathways.
The CJC-1295 w/o DAC 5mg + IPA 5mg blend is a premium research peptide combination supplied for laboratory studies involving growth hormone pathways, pituitary gland signaling, insulin like growth factor activity, body composition research, muscle growth models, and weight loss research.
This blend combines two peptides commonly studied together: CJC-1295 without DAC, a growth hormone releasing hormone analogue, and Ipamorelin, a growth hormone secretagogue. In research settings, CJC-1295 and Ipamorelin are often evaluated for their relationship to growth hormone release, muscle mass pathways, lean body mass, body fat models, sleep quality research, collagen synthesis, and cellular processes.
PremierPeptides™ supplies this product under strict quality control standards for non-clinical laboratory research only.
CJC 1295 Without DAC Research
CJC 1295 without DAC is studied as a growth hormone releasing hormone analogue. Researchers examine how it may influence the pituitary gland, growth hormone levels, GH releasing hormone pathways, and downstream insulin like growth factor signaling.
The “without DAC” distinction is important in research design. CJC-1295 without DAC is commonly discussed as a shorter-acting research compound compared to longer acting analogues. This may make it relevant in studies focused on brief growth hormone release patterns, pulse-like signaling, and pathway timing.
CJC-1295 has also been studied in clinical endocrinology research as a long-acting analogue of growth hormone releasing hormone, where researchers evaluated growth hormone and IGF-1 secretion in healthy adults. This scientific context does not mean CJC-1295 is approved for medical use, peptide therapy, anti aging treatment, muscle growth treatment, or weight loss treatment.
Growth Hormone and Ipamorelin Research
Ipamorelin is commonly studied as a growth hormone secretagogue. In research models, growth hormone secretagogues are evaluated for their ability to stimulate pathways involved in growth hormone release.
Researchers may study Ipamorelin in relation to:
Growth hormone signaling
Pituitary gland activity
Muscle tissue research
Lean mass and body composition models
Sleep quality and deep sleep pathways
Energy metabolism research
Collagen synthesis and skin quality models
Ipamorelin is often paired with CJC-1295 in research because the two peptides are studied through related but distinct mechanisms. This makes the blend relevant for studies comparing growth hormone releasing hormone activity with growth hormone secretagogue activity.
CJC 1295 and Ipamorelin for Muscle Mass Research
CJC 1295 and Ipamorelin are frequently discussed in studies involving muscle mass, lean muscle mass, lean body mass, and improved muscle mass models.
Research interest often focuses on how growth hormone pathways may affect muscle tissue, recovery-related processes, physical performance models, and body composition markers.
This product should not be described as a bodybuilding product, muscle-building supplement, or peptide therapy option. It is supplied only for controlled laboratory research.
Body Composition and Fat Loss Research
Body composition research often looks beyond body weight alone. Researchers may evaluate lean mass, body fat, stubborn fat models, metabolic signaling, insulin resistance pathways, and fat loss research markers.
CJC-1295 Ipamorelin research may be relevant to studies involving:
Body composition
Lean body mass
Body fat models
Weight loss research
Fat metabolism
Hormonal regulation
Growth hormone and IGF-related pathways
Quality Standards
Research accuracy depends on product consistency. Small differences in peptide identity, purity, storage, or batch quality can affect lab results and study interpretation.
PremierPeptides™ is built for researchers who value:
Third-party tested research peptides
Carefully selected raw materials
Minimum stated purity standards
Consistent batch quality
Clear research-use positioning
Canadian-owned fulfillment
Fast Canada-wide delivery
This product is intended for researchers looking for a reliable Canadian source for CJC-1295 and Ipamorelin blend research.
Research-Use Compliance
PremierPeptides™ products are supplied strictly for laboratory and scientific research.
This product is not intended for human consumption, animal use, injection, subcutaneous injection, oral administration, peptide therapy, ipamorelin therapy, treatment, anti aging use, muscle growth use, weight loss use, or medical use.
CJC-1295 and Ipamorelin are not approved consumer health products. Health Canada states that injectable peptides are regulated as prescription drugs in Canada, and unauthorized injectable peptide products may pose serious health risks because they have not been assessed for safety, efficacy, and quality. :contentReference[oaicite:1]{index=1}
Anyone seeking medical advice, peptide therapy, or treatment information should speak with a qualified medical provider or healthcare provider. A medical professional may review medical history, health history, lab tests, lab results, cardiovascular concerns, insulin resistance, hormone levels, other factors, and follow up visits as part of an appropriate clinical process.
PremierPeptides™ does not provide treatment plans, dosage instructions, injection guidance, peptide therapy journey support, or starting treatment recommendations.
Related Research Products
Researchers comparing similar growth hormone and body composition pathways may also review:
CJC-1295 Ipamorelin is studied in laboratory research involving growth hormone pathways, pituitary gland signaling, insulin like growth factor activity, muscle mass models, body composition, fat metabolism, sleep quality research, and collagen synthesis pathways.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 without DAC is commonly discussed as a shorter-acting research compound, while CJC-1295 with DAC is studied for longer-duration activity. Researchers may compare both depending on the study design, pathway timing, and desired growth hormone release model.
What are the benefits of CJC no DAC?
In research settings, CJC no DAC is studied for growth hormone releasing hormone pathways, brief GH signaling patterns, pituitary gland response, and insulin like growth factor activity. These are research applications only and should not be interpreted as human benefits.
What are CJC-1295 Ipamorelin benefits?
CJC-1295 and Ipamorelin are studied for their relationship to growth hormone signaling, muscle mass research, body composition models, recovery-related pathways, sleep quality research, and fat metabolism. PremierPeptides™ does not make human-use benefit claims.
What are CJC-1295 Ipamorelin side effects?
PremierPeptides™ products are not intended for human use, so we do not provide personal side effect guidance. In general peptide therapy discussions, reported concerns may include injection site reactions, water retention, nausea, appetite changes, and other potential risks. Medical questions should be directed to a qualified healthcare provider.
How to use CJC-1295 without DAC?
PremierPeptides™ does not provide use instructions, dosage guidance, injection instructions, cycle recommendations, or peptide therapy protocols. This product is supplied strictly for laboratory research and is not intended for human or animal use.
What is a CJC-1295 Ipamorelin dosage?
PremierPeptides™ does not provide CJC-1295 Ipamorelin dosage information. Researchers should follow approved laboratory protocols and institutional procedures. Anyone seeking medical information should consult a qualified medical provider.
How quickly does Ipamorelin work?
PremierPeptides™ does not provide human-use timelines or results claims. In research settings, timing can vary depending on study design, compound handling, model type, lab conditions, and measured endpoints.
Can Ipamorelin cause weight gain?
PremierPeptides™ does not provide personal health guidance. Ipamorelin is studied in relation to growth hormone pathways, appetite signaling, body composition, and metabolic research, but individual human outcomes are outside the scope of this research-use product page.
Is CJC-1295 Ipamorelin available in Canada?
PremierPeptides™ supplies CJC-1295 w/o DAC 5mg + IPA 5mg in Canada for laboratory research only. It is not supplied for peptide therapy, treatment, injection, bodybuilding, weight loss, anti aging, or human consumption.
Disclaimer
Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. They may contain high-risk ingredients, such as prescription or controlled drugs, and additives or contaminants that may or may not be listed on the label.
The level of active ingredients could be higher or lower than claimed and these ingredients could interact with other medications and foods. Prescription drugs should only be used under the care of a licensed health care professional because they are intended to treat specific conditions and may cause serious side effects. Prescription drugs can only be legally sold to consumers in Canada with a prescription.
Size
10mg
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
Free Shipping Canada-Wide On Orders Over $300. Quality Assured. 
Reviews
There are no reviews yet.